Revium Rx names Igor Bluvstein CFO, replacing Arie Gordashnikov

REVIUM RECOVERY INC

REVIUM RECOVERY INC

RVRC

0.00
  • Revium Rx. CFO Arie Gordashnikov resigned effective immediately on May 27, 2026; the departure was not tied to any reported disagreements.
  • Igor Bluvstein was appointed CFO effective immediately on May 27, 2026.
  • Bluvstein previously served as CFO of Argent BioPharma in 2024-2025, CFO of G Medical Innovations in 2022-2024.
  • He has more than 17 years of financial leadership experience across pharmaceuticals, digital health, biotech, e-commerce, petrochemicals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revium Rx. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-063235), on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.